Julia is an associate editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2022. She produces written and video content covering multiple disease states, and assists in the screening process for manuscripts submitted to AJMC®.
She has a BA in English language and literature from Rutgers University. You can connect with Julia on LinkedIn.
New eGFR Formula May Inappropriately Label Black Potential Kidney Donors as Having CKD
October 7th 2022This study found that the recent change to remove race from the calculation of estimated glomerular filtration rate (eGFR) may incorrectly label potential donors who are Black as having chronic kidney disease (CKD).
Read More
In AAO Lecture, AMA CEO Discusses How the Organization Is Addressing Areas of Innovation
October 3rd 2022During a lecture delivered at the American Academy of Ophthalmology (AAO) annual meeting, James Madara, MD, CEO of the American Medical Association, discussed 3 areas in ophthalmology care that required innovation to effectively push care into the 21st century.
Read More
Family Medicine Doctors, AI Could Be Effective in DR Screening
October 3rd 2022Posters presented at AAO 2022 found that family medicine doctors and artificial intelligence (AI) were able to screen patients for diabetic retinopathy (DR) effectively, although false negatives in AI need to be improved.
Read More
T&E Regimen, Consistent Adherence Important to Management of nAMD
October 2nd 2022Posters presented at the American Academy of Ophthalmology 2022 annual meeting show that the treat-and-extend (T&E) regimen was effective in managing neovascular age-related macular degeneration (nAMD), which makes adherence to treatment vital for long-term outcomes.
Read More
Which DME Drug to Try First? Patients on Bevacizumab Can Successfully Transition to Aflibercept
October 2nd 2022The presentation focused on the Protocol AC trial, which considered whether step therapy had an impact on visual outcomes for patients starting on bevacizumab and switching to aflibercept later.
Read More
Posters Emphasize Prevalence and Need for Prompt Treatment of RVO
September 30th 2022Posters presented at the American Academy of Ophthalmology 2022 annual meeting showed that patients with retinal vein occlusion (RVO) are most likely older with higher diastolic blood pressure, and they require prompt treatment to help manage the disease.
Read More
AAO Panel Offers Insight on Treatment Recommendations, In-Office Retina Surgery
September 30th 2022Speakers at a panel at the American Academy of Ophthalmology (AAO) 2022 conference spoke about future treatment options for patients in both minimally proven operations and in-office retina surgeries.
Read More
2 Commerce Drive
Cranbury, NJ 08512